PGI5 COSTS BENEFITS WITH ESOMEPRAZOLE 20MG 'ONDEMAND' TREATMENT IN GASTROESOPHAGEAL REFLUX DISEASE (GERD) PATIENTS IN BELGIUM

Nov 1, 2004, 00:00
10.1016/S1098-3015(10)66008-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66008-1/fulltext
Title : PGI5 COSTS BENEFITS WITH ESOMEPRAZOLE 20MG 'ONDEMAND' TREATMENT IN GASTROESOPHAGEAL REFLUX DISEASE (GERD) PATIENTS IN BELGIUM
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66008-1&doi=10.1016/S1098-3015(10)66008-1
First page :
Section Title :
Open access? : No
Section Order : 375
Categories :
Tags :
Regions :
ViH Article Tags :